Safety, efficacy, and PK/PD of a BCMA-targeted CAR-NK cell therapy (LUCAR-B68) in relapsed/refractory multiple myeloma: a phase I study

Digital Chinese Medicine · Elsevier

Аннотация

Publication date: Available online 2 October 2026 Source: Cytotherapy Author(s): Shan Meng, Fangxia Wang, Ying Shen, Yang Zhang, Xuehong Ma, Aili He, Wanhong Zhao

Читать у издателя →

Похожие статьи